ProCE Banner Activity

A Targeted Therapy Approach to Improving Patient Outcomes in NF1

Slideset Download
Download these slides from a live Webinar for the latest evidence on targeted therapy focused on MEK inhibitors for the management of plexiform neurofibromas in patients with NF1.

Released: June 22, 2021

Expiration: June 21, 2022

Share

Faculty

Brian D. Weiss

Brian D. Weiss, MD

Clinical Professor of Pediatrics
Division of Oncology
Cancer and Blood Diseases Institute
Cincinnati Childrens Hospital Medical Center
Medical Director, Solid Tumor Program
Division of Oncology
Cincinnati Childrens Hospital
Cincinnati, Ohio

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

AstraZeneca

Faculty Disclosure

Primary Author

Brian D. Weiss, MD

Clinical Professor of Pediatrics
Division of Oncology
Cancer and Blood Diseases Institute
Cincinnati Childrens Hospital Medical Center
Medical Director, Solid Tumor Program
Division of Oncology
Cincinnati Childrens Hospital
Cincinnati, Ohio